Håkon Stenmark1, Claudia Catani, Frank Neuner, Thomas Elbert, Are Holen. 1. Dept. of Neuroscience, Norwegian University of Science and Technology, 7489 Trondheim, Norway; Centre on Violence, Traumatic Stress and Suicide Prevention, Mid-Norway, St. Olav University Hospital, Schwacks Gt. 1, 7030 Trondheim, Norway. Electronic address: hakon.stenmark@stolav.no.
Abstract
OBJECTIVE: There has been uncertainty about whether refugees and asylum seekers with PTSD can be treated effectively in standard psychiatric settings in industrialized countries. In this study, Narrative Exposure Therapy (NET) was compared to Treatment As Usual (TAU) in 11 general psychiatric health care units in Norway. The focus was on changes in symptom severity and in the diagnostic status for PTSD and depression. METHOD: Refugees and asylum seekers fulfilling the DSM-IV criteria for PTSD (N = 81) were randomized with an a-priori probability of 2:1 to either NET (N = 51) or TAU (N = 30). The patients were assessed with Clinician Administered PTSD Scale, Hamilton rating scale for depression and the MINI Neuropsychiatric Interview before treatment, and again at one and six months after the completion. RESULTS: Both NET and TAU gave clinically relevant symptom reduction both in PTSD and in depression. NET gave significantly more symptom reduction compared to TAU as well as significantly more reduction in participants with PTSD diagnoses. No difference in treatment efficacy was found between refugees and asylum seekers. CONCLUSIONS: The study indicated that refugees and asylum seekers can be treated successfully for PTSD and depression in the general psychiatric health care system; NET appeared to be a promising treatment for both groups.
RCT Entities:
OBJECTIVE: There has been uncertainty about whether refugees and asylum seekers with PTSD can be treated effectively in standard psychiatric settings in industrialized countries. In this study, Narrative Exposure Therapy (NET) was compared to Treatment As Usual (TAU) in 11 general psychiatric health care units in Norway. The focus was on changes in symptom severity and in the diagnostic status for PTSD and depression. METHOD: Refugees and asylum seekers fulfilling the DSM-IV criteria for PTSD (N = 81) were randomized with an a-priori probability of 2:1 to either NET (N = 51) or TAU (N = 30). The patients were assessed with Clinician Administered PTSD Scale, Hamilton rating scale for depression and the MINI Neuropsychiatric Interview before treatment, and again at one and six months after the completion. RESULTS: Both NET and TAU gave clinically relevant symptom reduction both in PTSD and in depression. NET gave significantly more symptom reduction compared to TAU as well as significantly more reduction in participants with PTSD diagnoses. No difference in treatment efficacy was found between refugees and asylum seekers. CONCLUSIONS: The study indicated that refugees and asylum seekers can be treated successfully for PTSD and depression in the general psychiatric health care system; NET appeared to be a promising treatment for both groups.
Authors: Maria Mauritz; Peter Goossens; Ruud Jongedijk; Hester Vermeulen; Betsie van Gaal Journal: Front Psychiatry Date: 2022-04-28 Impact factor: 5.435
Authors: Ulrich Schnyder; Anke Ehlers; Thomas Elbert; Edna B Foa; Berthold P R Gersons; Patricia A Resick; Francine Shapiro; Marylène Cloitre Journal: Eur J Psychotraumatol Date: 2015-08-14
Authors: Shahin Zandieh; Reinhard Bernt; Peter Knoll; Thomas Wenzel; Karl Hittmair; Joerg Haller; Klaus Hergan; Siroos Mirzaei Journal: Medicine (Baltimore) Date: 2016-04 Impact factor: 1.889